The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Diagnosis and Treatment of Acute Coronary Syndromes: A Review
Abstract
IMPORTANCE: Acute coronary syndromes (ACS) are characterized by a sudden reduction in blood supply to the heart and include ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), and unstable angina. Each year, an estimated more than 7 million people in the world are diagnosed with ACS, including more than 1 million patients hospitalized in the US. OBSERVATIONS: Chest discomfort at rest is the most common presenting symptom of ACS and affects approximately 79% of men and 74% of women presenting with ACS, although approximately 40% of men and 48% of women present with nonspecific symptoms, such as dyspnea, either in isolation or, more commonly, in combination with chest pain. For patients presenting with possible ACS, electrocardiography should be performed immediately (within 10 minutes of presentation) and can distinguish between STEMI and non-ST-segment elevation ACS (NSTE-ACS). STEMI is caused by complete coronary artery occlusion and accounts for approximately 30% of ACS. ACS without significant ST-segment elevation on electrocardiography, termed NSTE-ACS, account for approximately 70% of ACS, are caused by partial or intermittent occlusion of the artery and are associated with ST-segment depressions (approximately 31%), T-wave inversions (approximately 12%), ST-segment depressions combined with T-wave inversions (16%), or neither (approximately 41%). When electrocardiography suggests STEMI, rapid reperfusion with primary percutaneous coronary intervention (PCI) within 120 minutes reduces mortality from 9% to 7%. If PCI within 120 minutes is not possible, fibrinolytic therapy with alteplase, reteplase, or tenecteplase at full dose should be administered for patients younger than 75 years without contraindications and at half dose for patients 75 years or older (or streptokinase at full dose if cost is a consideration), followed by transfer to a facility with the goal of PCI within the next 24 hours. High-sensitivity troponin measurements are the preferred test to evaluate for NSTEMI. In high-risk patients with NSTE-ACS and no contraindications, prompt invasive coronary angiography and percutaneous or surgical revascularization within 24 to 48 hours are associated with a reduction in death from 6.5% to 4.9%. CONCLUSIONS AND RELEVANCE: Each year, an estimated more than 7 million people are diagnosed with ACS worldwide. For patients with STEMI, coronary catheterization and PCI within 2 hours of presentation reduces mortality, with fibrinolytic therapy reserved for patients without access to immediate PCI. For high-risk patients with NSTE-ACS without contraindications, prompt invasive coronary angiography followed by percutaneous or surgical revascularization is associated with lower rates of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Self-citationAngiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Self-citationIntensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Fourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & The Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction (2018) · Circulation · doi:10.1161/cir.0000000000000617 · Cited by 3,799
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
Self-citationCardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Self-citationEplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Rivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
Self-citationNaghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087480.94275.97 · Cited by 2,270
Long-term use of ticagrelor in patients with prior myocardial infarction
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., Magnani, G., Bansilal, S., Fish, M. P., Im, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500857 · Cited by 1,999
Self-citationRivaroxaban in Patients with a Recent Acute Coronary Syndrome
Mega, J. L., Braunwald, E., Wiviott, S. D., Bassand, J.-P., Bhatt, D. L., Bode, C., Burton, P., Cohen, M., Cook-Bruns, N., Fox, K. A. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112277 · Cited by 1,897
Self-citationThe Norwegian Multicenter Study Group (1981) · New England Journal of Medicine · doi:10.1056/nejm198104023041401 · Cited by 1,675
Bhatt, D. L. (2006) · JAMA · doi:10.1001/jama.295.2.180 · Cited by 1,627
Self-citationPrevention of bleeding in patients with atrial fibrillation undergoing PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611594 · Cited by 1,590
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
Douglas, P. S., Hoffmann, U., Patel, M. R., Mark, D. B., Al-Khalidi, H. R., Cavanaugh, B., Cole, J., Dolor, R. J., Fordyce, C. B., Huang, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415516 · Cited by 1,543
Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30677-8 · Cited by 1,507
Zannad, F., Ferreira, J. P., Pocock, S. J., Anker, S. D., Butler, J., Filippatos, G., Brueckmann, M., Ofstad, A. P., Pfarr, E., Jamal, W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31824-9 · Cited by 1,408
Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708454 · Cited by 1,383
Self-citationOne-year cardiovascular event rates in outpatients with atherothrombosis
Steg, P. G., Bhatt, D. L., Wilson, P. W. F., D’Agostino, R., Ohman, E. M., Röther, J., Liau, C.-S., Hirsch, A. T., Mas, J.-L., Ikeda, Y., et al. (2007) · JAMA · doi:10.1001/jama.297.11.1197 · Cited by 1,382
Self-citationValgimigli, M., Gagnor, A., Calabró, P., Frigoli, E., Leonardi, S., Zaro, T., Rubartelli, P., Briguori, C., Andò, G., Repetto, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60292-6 · Cited by 1,303
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Self-citationAntithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., Goodman, S. G., Windecker, S., Darius, H., Li, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817083 · Cited by 1,228
Costa, F., van Klaveren, D., James, S., Heg, D., Räber, L., Feres, F., Pilgrim, T., Hong, M.-K., Kim, H.-S., Colombo, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30397-5 · Cited by 1,184
Self-citationTamis-Holland, J. E., Jneid, H., Reynolds, H. R., Agewall, S., Brilakis, E. S., Brown, T. M., Lerman, A., Cushman, M., Kumbhani, D. J., Arslanian-Engoren, C., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000670 · Cited by 994
Complete Revascularization with Multivessel PCI for Myocardial Infarction
Mehta, S. R., Wood, D. A., Storey, R. F., Mehran, R., Bainey, K. R., Nguyen, H., Meeks, B., Di Pasquale, G., López-Sendón, J., Faxon, D. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907775 · Cited by 940
Anand, S. S., Bosch, J., Eikelboom, J. W., Connolly, S. J., Diaz, R., Widimsky, P., Aboyans, V., Alings, M., Kakkar, A. K., Keltai, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32409-1 · Cited by 879
Self-citationPrasugrel versus clopidogrel for acute coronary syndromes without revascularization
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205512 · Cited by 874
Self-citationLawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 829
Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction
Armstrong, P. W., Gershlick, A. H., Goldstein, P., Wilcox, R., Danays, T., Lambert, Y., Sulimov, V., Rosell Ortiz, F., Ostojic, M., Welsh, R. C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301092 · Cited by 795
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909475 · Cited by 768
Triggering Myocardial Infarction by Marijuana
Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.23.2805 · Cited by 767
Arora, S., Stouffer, G. A., Kucharska-Newton, A. M., Qamar, A., Vaduganathan, M., Pandey, A., Porterfield, D., Blankstein, R., Rosamond, W. D., Bhatt, D. L., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037137 · Cited by 758
Self-citationConnolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32458-3 · Cited by 754
Self-citationBhatt, D. L., Eagle, K. A., Ohman, E. M., Hirsch, A. T., Goto, S., Mahoney, E. M., Wilson, P. W. F., Alberts, M. J., D’Agostino, R., Liau, C.-S., et al. (2010) · JAMA · doi:10.1001/jama.2010.1322 · Cited by 753
Self-citationSteg, P. G., Goldberg, R. J., Gore, J. M., Fox, K. A. A., Eagle, K. A., Flather, M. D., Sadiq, I., Kasper, R., Rushton-Mellor, S. K., & Anderson, F. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02489-x · Cited by 620
Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction
Maddox, T. M., Stanislawski, M. A., Grunwald, G. K., Bradley, S. M., Ho, P. M., Tsai, T. T., Patel, M. R., Sandhu, A., Valle, J., Magid, D. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.14681 · Cited by 571
Self-citationBenefit of Early Invasive Therapy in Acute Coronary Syndromes
Bavry, A. A., Kumbhani, D. J., Rassi, A. N., Bhatt, D. L., & Askari, A. T. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.050 · Cited by 556
Self-citationUdell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.279206 · Cited by 516
Self-citationPlaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction
Arbustini, E., Dal Bello, B., Morbini, P., Burke, A. P., Bocciarelli, M., Specchia, G., & Virmani, R. (1999) · Heart · doi:10.1136/hrt.82.3.269 · Cited by 477
Schmidt, M., Jacobsen, J. B., Lash, T. L., Botker, H. E., & Sorensen, H. T. (2012) · BMJ · doi:10.1136/bmj.e356 · Cited by 461
Writing Committee Members, Abraham, N. S., Hlatky, M. A., Antman, E. M., Bhatt, D. L., Bjorkman, D. J., Clark, C. B., Furberg, C. D., Johnson, D. A., Kahi, C. J., et al. (2010) · Circulation · doi:10.1161/cir.0b013e318202f701 · Cited by 451
Self-citationSafdar, B., Spatz, E. S., Dreyer, R. P., Beltrame, J. F., Lichtman, J. H., Spertus, J. A., Reynolds, H. R., Geda, M., Bueno, H., Dziura, J. D., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009174 · Cited by 451
Eikelboom, J. W., Anand, S. S., Malmberg, K., Weitz, J. I., Ginsberg, J. S., & Yusuf, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02324-2 · Cited by 447
Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes
Saw, J., Starovoytov, A., Humphries, K., Sheth, T., So, D., Minhas, K., Brass, N., Lavoie, A., Bishop, H., Lavi, S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz007 · Cited by 438
β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
Bangalore, S., Steg, G., Deedwania, P., Crowley, K., Eagle, K. A., Goto, S., Ohman, E. M., Cannon, C. P., Smith, S. C., Zeymer, U., et al. (2012) · JAMA · doi:10.1001/jama.2012.12559 · Cited by 436
Self-citationCardiogenic Shock After Acute Myocardial Infarction: A Review
Samsky, M. D., Morrow, D. A., Proudfoot, A. G., Hochman, J. S., Thiele, H., & Rao, S. V. (2021) · JAMA · doi:10.1001/jama.2021.18323 · Cited by 431
Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001030 · Cited by 428
Self-citationUdell, J. A., Bonaca, M. P., Collet, J.-P., Lincoff, A. M., Kereiakes, D. J., Costa, F., Lee, C. W., Mauri, L., Valgimigli, M., Park, S.-J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv443 · Cited by 370
Self-citationCoronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome
Ong, P., Athanasiadis, A., Hill, S., Vogelsberg, H., Voehringer, M., & Sechtem, U. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.050 · Cited by 350
Cardiovascular Effect of Bans on Smoking in Public Places
Meyers, D. G., Neuberger, J. S., & He, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.022 · Cited by 346
Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
Pfeffer, M. A., Claggett, B., Lewis, E. F., Granger, C. B., Køber, L., Maggioni, A. P., Mann, D. L., McMurray, J. J. V., Rouleau, J.-L., Solomon, S. D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2104508 · Cited by 307
Angiolillo, D. J., Bhatt, D. L., Cannon, C. P., Eikelboom, J. W., Gibson, C. M., Goodman, S. G., Granger, C. B., Holmes, D. R., Lopes, R. D., Mehran, R., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050438 · Cited by 302
Self-citationSpecial Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review
Bavishi, C., Bonow, R. O., Trivedi, V., Abbott, J. D., Messerli, F. H., & Bhatt, D. L. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.05.013 · Cited by 298
Self-citationFröbert, O., Götberg, M., Erlinge, D., Akhtar, Z., Christiansen, E. H., MacIntyre, C. R., Oldroyd, K. G., Motovska, Z., Erglis, A., Moer, R., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.057042 · Cited by 272
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
Bhatt, D. L. (2000) · JAMA · doi:10.1001/jama.284.12.1549 · Cited by 269
Self-citationTroponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes
Everett, B. M., Brooks, M. M., Vlachos, H. E. A., Chaitman, B. R., Frye, R. L., & Bhatt, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415921 · Cited by 268
Self-citationLeft Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment
McCarthy, C. P., Vaduganathan, M., McCarthy, K. J., Januzzi, J. L., Bhatt, D. L., & McEvoy, J. W. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1086 · Cited by 268
Self-citationKhan, A. R., Golwala, H., Tripathi, A., Bin Abdulhak, A. A., Bavishi, C., Riaz, H., Mallipedi, V., Pandey, A., & Bhatt, D. L. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx418 · Cited by 261
Self-citationvan Oosterhout, R. E. M., de Boer, A. R., Maas, A. H. E. M., Rutten, F. H., Bots, M. L., & Peters, S. A. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014733 · Cited by 255
Lopes, R. D., Hong, H., Harskamp, R. E., Bhatt, D. L., Mehran, R., Cannon, C. P., Granger, C. B., Verheugt, F. W. A., Li, J., ten Berg, J. M., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1880 · Cited by 240
Self-citationCoronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Linde, J. J., Kelbæk, H., Hansen, T. F., Sigvardsen, P. E., Torp-Pedersen, C., Bech, J., Heitmann, M., Nielsen, O. W., Høfsten, D., Kühl, J. T., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.012 · Cited by 206
Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017
Cross, S. H., Mehra, M. R., Bhatt, D. L., Nasir, K., O’Donnell, C. J., Califf, R. M., & Warraich, H. J. (2020) · JAMA · doi:10.1001/jama.2020.2047 · Cited by 185
Self-citationCardoso, R. N., Graffunder, F. P., Ternes, C. M. P., Fernandes, A. D. F., Rocha, A. V., Fernandes, G. C., & Bhatt, D. L. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100933 · Cited by 184
Self-citationKhan, S. U., Singh, M., Valavoor, S., Khan, M. U., Lone, A. N., Khan, M. Z., Khan, M. S., Mani, P., Kapadia, S. R., Michos, E. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046308 · Cited by 183
Self-citationCocaine and Marijuana Use Among Young Adults With Myocardial Infarction
DeFilippis, E. M., Singh, A., Divakaran, S., Gupta, A., Collins, B. L., Biery, D., Qamar, A., Fatima, A., Ramsis, M., Pipilas, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.047 · Cited by 176
Self-citationAragam, K. G., Dai, D., Neely, M. L., Bhatt, D. L., Roe, M. T., Rumsfeld, J. S., & Gurm, H. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.063 · Cited by 162
Self-citationChandrashekhar, Y., Alexander, T. H., Mullasari, A., Kumbhani, D. J., Alam, S., Alexánderson, E., Bachani, D., Badenhorst, J. C. W., Baliga, R. R., Bax, J. J., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041297 · Cited by 159
Self-citationBhatt, D. L., Eikelboom, J. W., Connolly, S. J., Steg, P. G., Anand, S. S., Verma, S., Branch, K. R. H., Probstfield, J., Bosch, J., Shestakovska, O., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046448 · Cited by 158
Self-citationEffect of Alirocumab on Mortality After Acute Coronary Syndromes
Steg, P. G., Szarek, M. J., Bhatt, D. L., Bittner, V., Brégeault, M.-F., Dalby, A. J., Díaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038840 · Cited by 153
Self-citationPercutaneous Coronary Intervention in 2018
Bhatt, D. L. (2018) · JAMA · doi:10.1001/jama.2018.5281 · Cited by 147
Self-citationMarijuana Use in Patients With Cardiovascular Disease
DeFilippis, E. M., Bajaj, N. S., Singh, A., Malloy, R. J., Givertz, M. M., Blankstein, R., Bhatt, D. L., & Vaduganathan, M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.025 · Cited by 147
Self-citationAcute coronary syndrome in the older adults
Alexander, K. P., Busby‐Whitehead, J., & Dai, X. (2016) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2016.02.012 · Cited by 146
The Relative Efficacy and Safety of Clopidogrel in Women and Men
Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.074 · Cited by 145
Self-citationOral Antiplatelet Therapy After Acute Coronary Syndrome: A Review
Kamran, H., Jneid, H. M., Kayani, W. T., Virani, S. S., Levine, G. N., Nambi, V., & Khalid, U. (2021) · JAMA · doi:10.1001/jama.2021.0716 · Cited by 141
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
Bhatt, D. L., Hulot, J., Moliterno, D. J., & Harrington, R. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302737 · Cited by 102
Self-citationBonaca, M. P., Bhatt, D. L., Ophuis, T. O., Steg, P. G., Storey, R. F., Cohen, M. C., Kuder, J., Im, K., Magnani, G., Budaj, A., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1017 · Cited by 100
Self-citationCardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule
Sugane, H., Kataoka, Y., Otsuka, F., Nakaoku, Y., Nishimura, K., Nakano, H., Murai, K., Honda, S., Hosoda, H., Matama, H., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.005 · Cited by 97
Biery, D. W., Berman, A. N., Singh, A., Divakaran, S., DeFilippis, E. M., Collins, B., Gupta, A., Fatima, A., Qamar, A., Klein, J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.9649 · Cited by 94
Self-citationChiang, C.-H., Chiang, C.-H., Pickering, J. W., Stoyanov, K. M., Chew, D. P., Neumann, J. T., Ojeda, F., Sörensen, N. A., Su, K.-Y., Kavsak, P., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1499 · Cited by 93
Capodanno, D., Maio, M. D., Greco, A., Bhatt, D. L., Gibson, C. M., Goette, A., Lópes, R. D., Mehran, R., Vranckx, P., & Angiolillo, D. J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017212 · Cited by 86
Self-citationCost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes
Bhatt, D. L., Briggs, A. H., Reed, S. D., Annemans, L., Szarek, M. J., Bittner, V., Díaz, R., Goodman, S. G., Harrington, R. A., Higuchi, K., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.029 · Cited by 67
Self-citationD’Ascenzo, F., Taha, S., Moretti, C., Omedè, P., Marra, W. G., Persson, J., Lamberts, M., Dewilde, W., Rubboli, A., Manzano‐Fernández, S., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.02.003 · Cited by 65
Nakayama, N., Kaikita, K., Fukunaga, T., Matsuzawa, Y., Sato, K., Horio, E., Yoshimura, H., Mizobe, M., Takashio, S., Tsujita, K., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000795 · Cited by 64
Eikelboom, J. W., Bhatt, D. L., Fox, K. A. A., Bosch, J., Connolly, S. J., Anand, S. S., Avezum, Á., Berkowitz, S. D., Branch, K. R., Dagenais, G. R., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.083 · Cited by 63
Self-citationThrane, P. G., Kristensen, S. D., Olesen, K. K. W., Mortensen, L. S., Bøtker, H. E., Thuesen, L., Hansen, H. S., Abildgaard, U., Engstrøm, T., Andersen, H., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz595 · Cited by 60
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease
Atti, V., Gwon, Y., Narayanan, M. A., Garcia, S. A., Sandoval, Y. B., Brilakis, E. S., Basir, M. B., Turagam, M. K., Khandelwal, A. K., Mena‐Hurtado, C., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.04.055 · Cited by 49
Self-citationDawson, L. P., Chen, D. C., Dagan, M., Bloom, J. E., Taylor, A. J., Duffy, S. J., Shaw, J. A., Lefkovits, J., & Stub, D. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34322 · Cited by 34
Tan, N. S., Goodman, S. G., Yan, R. T., Elbarouni, B., Budaj, A., Fox, K. A. A., Gore, J. M., Brieger, D. B., Lopez-Sendon, J. L., Langer, A., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.04.010 · Cited by 31
Bravo, C., Hirji, S. A., Bhatt, D. L., Kataria, R., Faxon, D. P., Ohman, E. M., Anderson, K. L., Sidi, A. I., Sketch, M. H., ZARICH, S. W., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011986.pub2 · Cited by 31
Self-citationMontalescot, G., Drexler, H., Gallo, R., Pearson, T. A., Thoenes, M., & Bhatt, D. L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp301 · Cited by 16
Self-citationLópes, R. D., Leonardi, S., Neely, B., Neely, M. L., Ohman, E. M., Ardissino, D., Hamm, C. W., Goodman, S. G., Bhatt, D. L., White, H. D., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.034 · Cited by 15
Self-citation
Cited by
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · JACC · doi:10.1016/j.jacc.2024.11.009 · Cited by 552
Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective
Razavi, Z.-S., Soltani, M., Mahmoudvand, G., Farokhi, S., Karimi-Rouzbahani, A., Farasati-Far, B., Tahmasebi-Ghorabi, S., Pazoki-Toroudi, H., & Afkhami, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1385124 · Cited by 64
Chen, Q., Zheng, A., Xu, X., Shi, Z., Yang, M., Sun, S., Wang, L., Wang, Y., Zhao, H., Xiao, Q., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.070286 · Cited by 54
Li, H., Chen, J., Lu, J., Yang, J., Tan, Z., Li, L., Xiao, F., An, Z., Ma, C., Liu, Y., et al. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2022.137464 · Cited by 35
Metadata
- Authors
- Bhatt, D. L., Lopes, R. D., & Harrington, R. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2022-02-15
- Volume
- 327
- Issue
- 7
- Pages
- 662
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4213285159
- Cited by
- 787
- References
- 105
- FWCI
- 100.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.